A tailored course, built for your situation
Risk-Managed AI in Pharmaceutical R&D Operations for Mid-Market Operations
A structured, implementation-grade path to governing AI in drug development with confidence and compliance
$199 one-time
24-hour access provisioning
30-day money-back guarantee
Hand-built implementation playbook
12 modules. 12 chapters per module. 144 chapters total.
12 modules, each with 12 chapters (144 chapters total), text-based, plus downloadable templates and a hand-built implementation playbook delivered alongside course access.
AI adoption in pharma R&D is accelerating, but without structured risk controls, teams face compliance gaps and operational drift.
The situation this course is for
Mid-market pharmaceutical organizations are advancing AI use in R&D, yet lack standardized frameworks to ensure compliance, audit readiness, and cross-functional alignment. This leads to fragmented implementations, rework, and hesitation at leadership levels despite clear efficiency gains.
Who this is for
Business and technology professionals in mid-market pharmaceutical organizations driving AI adoption in R&D operations, with responsibilities spanning compliance, data governance, project delivery, or operational leadership.
Who this is not for
Entry-level analysts without decision-making scope, vendors selling AI tools without implementation experience, or executives seeking only high-level overviews without hands-on frameworks.
What you walk away with
- Apply a standardized risk classification model to AI use cases in drug discovery and clinical development
- Design compliant AI workflows that align with FDA and EMA expectations
- Integrate model monitoring and validation into existing R&D pipelines
- Lead cross-functional AI governance committees with structured decision frameworks
- Deploy AI initiatives with documented controls for audit and scalability
The 12 modules (with all 144 chapters)
Module 1. Foundations of AI in Pharmaceutical R&D
Understand the current landscape of AI adoption in drug development and the shift toward risk-managed deployment.
12 chapters in this module
- Defining AI in the context of pharmaceutical R&D
- Evolution of computational methods in drug discovery
- Mid-market challenges and opportunities
- Regulatory expectations for AI-enabled development
- Key differences between research AI and operational AI
- AI maturity models for pharma organizations
- Common use cases in target identification and screening
- Data infrastructure prerequisites
- Ethical considerations in AI-driven research
- Stakeholder alignment across R&D and compliance
- Benchmarking current capabilities
- Assessing organizational readiness
Module 2. Risk Classification Frameworks for AI
Implement a tiered risk model to categorize AI applications by impact, compliance exposure, and auditability.
12 chapters in this module
- Principles of risk-based AI governance
- Designing a risk taxonomy for pharma R&D
- Low vs. high-impact AI applications
- Regulatory scrutiny levels by use case
- Mapping AI functions to GxP obligations
- Developing risk scoring criteria
- Documenting risk determinations
- Engaging QA and regulatory affairs early
- Versioning risk assessments
- Integrating risk tiers into project intake
- Case study: AI in toxicology prediction
- Case study: AI in clinical trial site selection
Module 3. Compliance by Design in AI Workflows
Embed compliance requirements directly into AI development and deployment pipelines.
12 chapters in this module
- Principles of compliance by design
- Integrating ALCOA+ into AI data flows
- Data lineage for model training sets
- Audit trail requirements for AI decisions
- Electronic records and signatures (21 CFR Part 11)
- Validation of AI-driven processes
- Change control for model updates
- Deviation management for AI anomalies
- Documentation standards for AI models
- Training requirements for AI users
- Vendor AI tools and compliance oversight
- Preparing for regulatory inspections
Module 4. Model Development Lifecycle Governance
Apply structured governance across the AI model lifecycle from ideation to retirement.
12 chapters in this module
- Phases of the AI model lifecycle
- Idea submission and prioritization
- Feasibility assessment and scoping
- Data acquisition and curation plans
- Model development standards
- Internal review and validation gates
- Pilot deployment and monitoring
- Performance benchmarking
- Scaling criteria and handoff
- Model versioning and archiving
- Retirement and replacement planning
- Cross-functional governance board roles
Module 5. Data Governance for AI in R&D
Establish robust data controls tailored to AI use in pharmaceutical development.
12 chapters in this module
- Data quality metrics for AI readiness
- Master data management in R&D
- Metadata standards for AI training sets
- Data access and role-based permissions
- Data provenance tracking
- Handling unstructured data in AI pipelines
- Data versioning and lineage tools
- Anonymization and privacy in R&D data
- Data retention and disposal
- Vendor data handling compliance
- Data incident response for AI systems
- Auditing data governance practices
Module 6. AI Validation and Verification
Implement rigorous validation protocols for AI models in regulated environments.
12 chapters in this module
- Validation vs. verification in AI
- Developing test plans for AI models
- Performance metrics for AI accuracy
- Bias and fairness testing
- Reproducibility of AI outputs
- Stress testing under edge cases
- Comparing AI to traditional methods
- Statistical validation techniques
- Documentation for validation reports
- Independent review processes
- Ongoing monitoring post-deployment
- Revalidation triggers
Module 7. Operational Integration of AI Models
Seamlessly embed validated AI models into existing R&D workflows.
12 chapters in this module
- Process mapping for AI integration
- Change management for AI adoption
- User training and support plans
- Integration with LIMS and ELN systems
- Workflow automation with AI triggers
- Human-in-the-loop design
- Error handling and escalation paths
- Monitoring AI performance in production
- Feedback loops for model improvement
- Scaling AI across therapeutic areas
- Managing technical debt in AI systems
- Resource planning for AI operations
Module 8. Regulatory Strategy for AI-Enabled Submissions
Prepare regulatory dossiers that transparently include AI-generated data and insights.
12 chapters in this module
- Regulatory pathways for AI in drug development
- FDA and EMA guidance on AI/ML
- Documentation requirements for AI components
- Transparency in model methodology
- Validation evidence for regulatory review
- Labeling considerations for AI-driven decisions
- Post-market surveillance for AI models
- Inspection readiness for AI systems
- Engaging regulators proactively
- Case study: AI in clinical trial analysis
- Case study: AI in manufacturing process optimization
- Future regulatory trends
Module 9. AI Governance Committee Structure
Design and operate a cross-functional governance body to oversee AI deployment.
12 chapters in this module
- Purpose and scope of AI governance
- Stakeholder representation
- Charter development and approval
- Meeting cadence and decision logs
- Risk escalation protocols
- Policy development and enforcement
- Audit coordination
- Training oversight
- Performance reporting
- Continuous improvement of governance
- Conflict resolution mechanisms
- External advisor engagement
Module 10. Third-Party and Vendor AI Management
Govern AI solutions developed or provided by external partners.
12 chapters in this module
- Vendor due diligence for AI tools
- Contractual requirements for AI compliance
- Audit rights and transparency clauses
- Data ownership and IP considerations
- Performance SLAs for AI vendors
- Change control for vendor updates
- Integration testing with internal systems
- Oversight of vendor model training
- Incident response coordination
- Exit strategies and data portability
- Multi-vendor AI ecosystem management
- Benchmarking vendor performance
Module 11. AI Monitoring and Continuous Improvement
Establish ongoing oversight to maintain AI model integrity and performance.
12 chapters in this module
- Key performance indicators for AI models
- Automated monitoring dashboards
- Alerting for model drift
- Regular performance reviews
- Feedback from end users
- Model retraining workflows
- Version control and deployment
- Incident logging and analysis
- Root cause analysis for AI errors
- Improvement backlog management
- Scaling monitoring across models
- Reporting to governance committees
Module 12. Scaling AI Across the Organization
Expand AI adoption while maintaining governance, compliance, and operational integrity.
12 chapters in this module
- Enterprise AI strategy alignment
- Portfolio management of AI initiatives
- Resource allocation models
- Center of excellence design
- Knowledge sharing frameworks
- Standardized templates and playbooks
- Cross-therapeutic area collaboration
- Measuring ROI of AI programs
- Talent development and upskilling
- Succession planning for AI leads
- External benchmarking and partnerships
- Future roadmap planning
How this maps to your situation
- R&D teams advancing AI in discovery and development
- Compliance and QA leaders overseeing AI integration
- Data governance officers establishing AI controls
- Operations leads scaling AI across therapeutic areas
Before vs. after
Before
AI initiatives proceed in silos, with inconsistent risk assessment, limited compliance integration, and reactive governance.
After
AI is deployed systematically with clear risk controls, embedded compliance, and cross-functional oversight, enabling scalable innovation.
What's included with your purchase
- 12 modules with 12 chapters each (144 chapters)
- Downloadable templates and worked examples for every module
- Hand-built implementation playbook delivered alongside course access
- 30-day money-back guarantee
Delivery and format
- Course and learning environment access provisioned within 24 hours of purchase
- Hand-built implementation playbook delivered alongside course access
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.
Time investment: Approximately 60 hours of self-paced learning, designed for professionals balancing active roles in R&D and operations.
If nothing changes
Without structured governance, organizations risk regulatory scrutiny, project failures, and missed opportunities to leverage AI at scale.
How this compares to the alternatives
Unlike generic AI courses, this program is tailored to mid-market pharmaceutical organizations, combining regulatory depth with implementation precision. It goes beyond theory to deliver actionable frameworks, checklists, and governance models specifically for AI in drug development.
Frequently asked
Who is this course for?
It's designed for business and technology professionals in mid-market pharma organizations leading AI adoption in R&D, with responsibilities in compliance, data governance, operations, or project delivery.
How is the course structured?
12 modules, each containing 12 chapters (144 chapters total).
Is this course technical or strategic?
It balances both, delivering strategic governance frameworks and practical implementation tools for real-world deployment.
$199 one-time. Approximately 60 hours of self-paced learning, designed for professionals balancing active roles in R&D and operations..
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.
30-day money-back guarantee·
144 chapters·
Hand-built playbook included·
Account access within 24 hours